van Oort I - Search Results

1

Urologists' and GPs' knowledge of hereditary prostate cancer is suboptimal for prostate cancer counseling: a nation-wide survey in The Netherlands.

Cremers R, van Asperen C, Kil P, Vasen H, Wiersma T, van Oort I, Kiemeney L. Cremers R, et al. Among authors: van oort i, van asperen c. Fam Cancer. 2012 Jun;11(2):195-200. doi: 10.1007/s10689-011-9500-8. Fam Cancer. 2012. PMID: 22160565 Free PMC article.

2

DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer.

Hessels D, Klein Gunnewiek JM, van Oort I, Karthaus HF, van Leenders GJ, van Balken B, Kiemeney LA, Witjes JA, Schalken JA. Hessels D, et al. Among authors: van balken b, van oort i, van leenders gj. Eur Urol. 2003 Jul;44(1):8-15; discussion 15-6. doi: 10.1016/s0302-2838(03)00201-x. Eur Urol. 2003. PMID: 12814669

3

Does the tertiary Gleason pattern influence the PSA progression-free interval after retropubic radical prostatectomy for organ-confined prostate cancer?

van Oort IM, Schout BM, Kiemeney LA, Hulsbergen CA, Witjes JA. van Oort IM, et al. Eur Urol. 2005 Oct;48(4):572-6. doi: 10.1016/j.eururo.2005.06.003. Eur Urol. 2005. PMID: 16046051

4

The prognostic value of E-cadherin and the cadherin-associated molecules alpha-, beta-, gamma-catenin and p120ctn in prostate cancer specific survival: a long-term follow-up study.

van Oort IM, Tomita K, van Bokhoven A, Bussemakers MJ, Kiemeney LA, Karthaus HF, Witjes JA, Schalken JA. van Oort IM, et al. Among authors: van bokhoven a. Prostate. 2007 Sep 15;67(13):1432-8. doi: 10.1002/pros.20626. Prostate. 2007. PMID: 17639504

5

Maximum tumor diameter is not an independent prognostic factor in high-risk localized prostate cancer.

van Oort IM, Witjes JA, Kok DE, Kiemeney LA, Hulsbergen-vandeKaa CA. van Oort IM, et al. World J Urol. 2008 Jun;26(3):237-41. doi: 10.1007/s00345-008-0242-7. Epub 2008 Feb 12. World J Urol. 2008. PMID: 18265988 Free PMC article.

6

The prognostic role of the pathological T2 subclassification for prostate cancer in the 2002 Tumour-Nodes-Metastasis staging system.

van Oort IM, Witjes JA, Kok DE, Kiemeney LA, Hulsbergen-Van De Kaa CA. van Oort IM, et al. BJU Int. 2008 Aug;102(4):438-41. doi: 10.1111/j.1464-410X.2008.07611.x. Epub 2008 Mar 11. BJU Int. 2008. PMID: 18336608

7

A single institution experience with biochemical recurrence after radical prostatectomy for tumors that on pathology are of small volume or "insignificant".

van Oort IM, Kok DE, Kiemeney LA, Hulsbergen-van de Kaa CA, Witjes JA. van Oort IM, et al. Urol Oncol. 2009 Sep-Oct;27(5):509-13. doi: 10.1016/j.urolonc.2008.04.014. Epub 2008 Jul 14. Urol Oncol. 2009. PMID: 18625570

8

Body mass index as a prognostic marker for biochemical recurrence in Dutch men treated with radical prostatectomy.

van Roermund JG, Kok DE, Wildhagen MF, Kiemeney LA, Struik F, Sloot S, van Oort IM, Hulsbergen-van de Kaa CA, van Leenders GJ, Bangma CH, Witjes JA. van Roermund JG, et al. BJU Int. 2009 Aug;104(3):321-5. doi: 10.1111/j.1464-410X.2009.08404.x. Epub 2009 Feb 11. BJU Int. 2009. PMID: 19220264

9

[Multiparametric MRI for prostate cancer screening].

Hoeks CM, Fütterer JJ, Somford DM, van Oort IM, Huisman H, Barentsz JO. Hoeks CM, et al. Ned Tijdschr Geneeskd. 2009;153:B487. Ned Tijdschr Geneeskd. 2009. PMID: 20003566 Review. Dutch.

10

Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen.

Hambrock T, Somford DM, Hoeks C, Bouwense SA, Huisman H, Yakar D, van Oort IM, Witjes JA, Fütterer JJ, Barentsz JO. Hambrock T, et al. J Urol. 2010 Feb;183(2):520-7. doi: 10.1016/j.juro.2009.10.022. Epub 2009 Dec 14. J Urol. 2010. PMID: 20006859

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

164 results

Search Page